Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1330 Breast Neoplasms 686 Carcinoma, Non-Small-Cell Lung 543 Neoplasm Metastasis 436 Lymphoma 435 Leukemia, Myeloid, Acute 432 Melanoma 402 Prostatic Neoplasms 380 Multiple Myeloma 364 Lymphoma, Non-Hodgkin 355 Ovarian Neoplasms 343 Colorectal Neoplasms 333 Precursor Cell Lymphoblastic Leukemia-Lymphoma 328 Pancreatic Neoplasms 328 Leukemia, Lymphocytic, Chronic, B-Cell 323 Leukemia 282 Lung Neoplasms 275 Glioblastoma 266 Unspecified Adult Solid Tumor, Protocol Specific 257 Recurrence 252 Lymphoma, Follicular 248 Lymphoma, Large B-Cell, Diffuse 245 Brain Neoplasms 232 Lymphoma, Mantle-Cell 210 Carcinoma, Renal Cell 193 Hodgkin Disease 192 Head and Neck Neoplasms 192 Myelodysplastic Syndromes 187 Burkitt Lymphoma 172 Glioma 171

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Completed × Aggression × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡